• Welcome!

    Acute and Long COVID-19

    Learn more

  • Pipeline

    Review our self immunization protocol against cancers through our pipeline.

    Learn More

  • EdgePoint AI

    Introducing our revolutionary cluster-computer platform for AI processing.

    Learn more
123

Investor Relations

Press, quotes, SEC filings, alerts, more.

View Now

COVID-19

OT-101 for COVID-19

Learn More

Pipeline

Cancer and viral infection treatment information.

Details

EdgePoint AI

Core cloud-computer AI platform.

Overview

Most recent news and events

Oncotelic Happenings

Dr. Cynthia Lee etc. presented at the SNO 2022 conference (November 16-20, 2022 | Tampa bay, FL) Learn more 1> Learn more 2>

Dr. Anthony Maida presented at the SITC 2022 conference (November 8-12, 2022 | Boston, MA) Learn more >

Dr. Vuong Trieu presented at the 7th JCA-AACR Special Joint Conference (July 8-10, 2022) Learn more >

Dr. Vuong Trieu presented at the BIO International Convention, San Diego (June 13-16, 2022) Learn more >

AACR Annual Meeting 2022. April 8 – 13, 2022, New Orleans, Louisiana. Learn more >

Dr. Vuong Trieu presented at the MedInvest Pharmaceutical & Biotechnology Investor Conference (March 30-31, 2022) Learn more >

Biotechgate Digital Partnering February 2022 (7 – 11 Feb, 2022) Learn more >

2nd Annual TGF-β for Immuno-Oncology Drug Development Summit (tgf-beta-summit.com) (January 25, 2022 to January 27, 2022) Learn more >

Oncotelic Therapeutics Investor Presentation 10-26-2021. Learn more >

11 Billion $

target markets

100 Plus

patent applications

2 Key

clinical programs

30 Years

experience

Copyright © 2020 Oncotelic Inc., a TGF ImmunoOncology Company. All rights reserved.